References
- Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem. 2011;57(6):1–47.
- Bry L, Chen PC, Sacks DB. Effects of hemoglobin variants and chemically modified derivatives on assays for glycohemoglobin. Clin Chem. 2001;74(2):153–63.
- Hardison RC, Chui DHK, Giardine B, Riemer C, Patrinos GP, Anagou N, et al. HbVar: a relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mut. 2002;19(3):225–233 [cited 2014 April 1]. Available from: http://globin.cse.psu.edu.
- Waitumbi JN, Kifude CM, Withers MR, Polhemus ME, Heppner DG, Ogutu BR. Hb G-Philadelphia or Stanleyville II? When the phenotype and genotype do not agree? Eur J Haematol. 2007;79:177–8.
- Vella F, Hill JR, Wiltshire B, Lehmann H. Hemoglobin J Toronoto, Clin Biochem. 1971;4:137–40.
- Speeckaert M, Van Biesen W, Delanghe J, Slingerland R, Wiecek A, Heaf J, et al. Are there better alternatives than haemoglobin A1c to estimate glycaemic control in the chronic kidney disease population? Nephrol Dial Transplant. Epub ahead of print 26 January 2014, DOI: 10.1093/ndt/gfu006.
- Crookston JH, Beale D, Irvine D, Lehmann H. A new haemoglobin, J Toronto (alpha-5 alanine to aspartic acid). Nature. 1965;208:1059–61.